Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
881 participants
OBSERVATIONAL
2022-07-07
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genital Hygiene Training Provided to Turkish Women
NCT05998668
Genital Hygiene Education and Pregnancy
NCT06791252
Genital Hygiene Education on Women's Self-Care Agency and Genital Hygiene Behaviors
NCT07341035
The Relationship Between Nurse-Led Health Belief Model-Based Education and Genital Hygiene and UTI Prevention Attitudes
NCT06891404
The Effect of Web Based Genital Hygiene Education Provided to Orthopedically Disabled Women
NCT04723381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data Collection Tools Data for the study was collected through the "Data Collection Form" and "Genital Hygiene Behaviors Inventory", created by the researchers by reviewing the literature (Karahan, 2017; Cankaya, 2013; Elzayat et al. 2017; Adam and Saadia, 2016; Akgul, 2019).
Data collection form: A survey consisting of 13 questions about the age of the women, the amount of water consumed daily, the number of urinations, the genital infection status, and sexuality.
Genital Hygiene Behaviors Inventory - GHBI: A scale, developed by Karahan (2017), and for which written permission for use was obtained, consisting of 23 items in total and 3 sub-dimensions: "genital hygiene behaviors", "menstrual habits" and "abnormal findings". Items 1-12 evaluate genital hygiene, items 13-20 evaluate menstrual hygiene, and items 21-23 evaluate the awareness of abnormal findings. Items 7, 14, 19, 20 and 23 of the scale are the reversed items and are reverse coded during the evaluation. A minimum total of 23 and a maximum total of 115 points can be obtained from the 5-point Likert-type scale, where "1" point means "I totally disagree" and "5" points means "I completely agree". Higher scale scores correspond to better genital hygiene behaviors. The study evaluating the development of the scale and its validity and reliability determined the Cronbach's Alpha coefficient as 0.80 (Karahan, 2017); our study's Cronbach's Alpha coefficient was 0.78.
Data Collection The prepared data collection form and the scale were transferred to the computer environment and delivered online to the women through the snowball sampling method. It took approximately 10 minutes for each participant to complete the data collection forms Data Analysis The data collected in the study was analyzed using the Statistical Package for the Social Sciences, version 25.0 (SPSS, v25.0) statistical analysis package program (IBM Company, Turkey). First the descriptive data of the study was analyzed. Mean, median, standard deviation, minimum and maximum values were calculated in the analysis of continuous data, and numbers and percentages were calculated in the analysis of categorical data. Next, non-parametric and parametric tests were used according to normality distributions. Pearson Chi-square test, Kruskal Wallis Test and Mann Whitney-U tests were used to analyze the data. A simple linear regression analysis model was used to determine the factors affecting genital hygiene behaviors. Statistical significance level was accepted as p\<.05 at 95% confidence interval.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
There is no intervention. The research is cross-sectional-descriptive type.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To speak and understand Turkish,
* women
Exclusion Criteria
* dont want to participate the research
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esra Çalışkan
Phd Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esra Çalışkan, Msc
Role: STUDY_DIRECTOR
Istanbul University - Cerrahpasa
References
Explore related publications, articles, or registry entries linked to this study.
Emiru T, Beyene G, Tsegaye W, Melaku S. Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia. BMC Res Notes. 2013 Jul 25;6:292. doi: 10.1186/1756-0500-6-292.
Minardi D, d'Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: etiology and treatment options. Int J Gen Med. 2011;4:333-43. doi: 10.2147/IJGM.S11767. Epub 2011 Apr 19.
Abdel-Aziz Elzayat M, Barnett-Vanes A, Dabour MF, Cheng F. Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt. BMJ Open. 2017 Mar 21;7(3):e013198. doi: 10.1136/bmjopen-2016-013198.
Haider G, Zehra N, Munir AA, Haider A. Risk factors of urinary tract infection in pregnancy. J Pak Med Assoc. 2010 Mar;60(3):213-6.
Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am. 1997 Sep;11(3):719-33. doi: 10.1016/s0891-5520(05)70382-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECaliskan1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.